You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
|
|---|---|
| Published in |
Experimental Hematology & Oncology, April 2019
|
| DOI | 10.1186/s40164-019-0133-1 |
| Pubmed ID | |
| Authors |
Stefanie Jilg, Richard T. Hauch, Johanna Kauschinger, Lars Buschhorn, Timo O. Odinius, Veronika Dill, Catharina Müller-Thomas, Tobias Herold, Peter M. Prodinger, Burkhard Schmidt, Dirk Hempel, Florian Bassermann, Christian Peschel, Katharina S. Götze, Ulrike Höckendorf, Torsten Haferlach, Philipp J. Jost |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 10 | 19% |
| Student > Ph. D. Student | 8 | 15% |
| Researcher | 6 | 12% |
| Student > Postgraduate | 5 | 10% |
| Other | 4 | 8% |
| Other | 8 | 15% |
| Unknown | 11 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 40% |
| Biochemistry, Genetics and Molecular Biology | 9 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
| Agricultural and Biological Sciences | 3 | 6% |
| Immunology and Microbiology | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 12 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2019.
All research outputs
#15,571,060
of 23,144,579 outputs
Outputs from Experimental Hematology & Oncology
#152
of 301 outputs
Outputs of similar age
#199,092
of 319,127 outputs
Outputs of similar age from Experimental Hematology & Oncology
#3
of 6 outputs
Altmetric has tracked 23,144,579 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 301 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,127 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.